NCT04184102
- Conditions
- Behavior, Hemic and Lymphatic Diseases, Lymphatic Diseases, +3 more
- Locations
-
- American University Medical Center (AUBMC) Beirut, Lebanon
Clinical trial condition
Lymphatic Diseases
Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
9,012 public trials
1,844 recruiting studies
Lymphatic Diseases trial results
NCT00974233
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- St Vincent Regional Cancer Center Green Bay, Wisconsin, United States
- Bellin Memorial Hospital Green Bay, Wisconsin, United States
- Mercy Health System Heme/Onc Janesville, Wisconsin, United States
- Gundersen Clinic La Crosse, Wisconsin, United States
NCT02391480
- Conditions
- Acute Myeloid Leukemia (AML), Blood Protein Disorders, Breast Cancer, +47 more
- Locations
-
- Scottsdale Healthcare /ID# 132963 Scottsdale, Arizona, United States
- City of Hope /ID# 154053 Duarte, California, United States
- UC Davis Comp Cancer Ctr /ID# 154644 Sacramento, California, United States
- Yale University /ID# 136982 New Haven, Connecticut, United States
NCT02254772
- Conditions
- Chronic Disease, Disease Attributes, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, +25 more
- Locations
-
- Stanford University Hospitals and Clinics Stanford, California, United States
Completed
Chronic Fatigue in Sarcoidosis
NCT04178239
- Conditions
- Fatigue, Hemic and Lymphatic Diseases, Hypersensitivity, +7 more
- Locations
-
- University Hospital RWTH Aachen Aachen, North Rhine-Westphalia, Germany
NCT02228772
- Conditions
- Acute Lymphoblastic Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, Hematologic Diseases, +12 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Completed
Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer
NCT01324323
- Conditions
- Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +10 more
- Locations
-
- Florida Cancer Specialists Sarasota, Florida, United States
- Sarah Canon Research Institute Nashville, Tennessee, United States
- Sarah Cannon Research UK London, United Kingdom
Completed
Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer
NCT01324310
- Conditions
- Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +10 more
- Locations
-
- Florida Cancer Specialists Sarasota, Florida, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
- Sarah Cannon Research UK London, United Kingdom
NCT01353664
- Conditions
- Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
- Locations
-
- Florida Cancer Specialists Sarasota, Florida, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
- Sarah Cannon Research UK London, United Kingdom
NCT01197560
- Conditions
- Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Providence St Joseph Medical Center/Cancer Center Burbank, California, United States
- MD Anderson Cancer Center Orlando Orlando, Florida, United States
- Emory University Atlanta, Georgia, United States
- Northwestern University Chicago, Illinois, United States